Cancer (Tumor) Profiling Market Report

China Cancer (Tumor) Profiling Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 23, 2022
  • PAGES：219
  • REPORT CODE：GMM1127055
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Cancer (Tumor) Profiling market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Cancer (Tumor) Profiling market. Detailed analysis of key players, along with key growth strategies adopted by Cancer (Tumor) Profiling industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • HTG Molecular Diagnostics

    • Ribomed Biotechnologies

    • Caris Life Sciences

    • Helomics Corporation

    • Neogenomics Laboratories

    • Nanostring Technologies

    • Genomic Health

    • Qiagen

    • Illumina

    • Oxford Gene Technology

    By Type:

    • Immunoassay

    • Hybridization

    • NGS

    • Mass Spectrometry

    By End-User:

    • Clinical

    • Research

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer (Tumor) Profiling Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Cancer (Tumor) Profiling Market Size and Growth Rate of Immunoassay from 2016 to 2027

    • 1.3.2 China Cancer (Tumor) Profiling Market Size and Growth Rate of Hybridization from 2016 to 2027

    • 1.3.3 China Cancer (Tumor) Profiling Market Size and Growth Rate of NGS from 2016 to 2027

    • 1.3.4 China Cancer (Tumor) Profiling Market Size and Growth Rate of Mass Spectrometry from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Cancer (Tumor) Profiling Market Size and Growth Rate of Clinical from 2016 to 2027

    • 1.4.2 China Cancer (Tumor) Profiling Market Size and Growth Rate of Research from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Cancer (Tumor) Profiling Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cancer (Tumor) Profiling by Major Types

    • 3.4.1 Market Size and Growth Rate of Immunoassay

    • 3.4.2 Market Size and Growth Rate of Hybridization

    • 3.4.3 Market Size and Growth Rate of NGS

    • 3.4.4 Market Size and Growth Rate of Mass Spectrometry

    4 Segmentation of Cancer (Tumor) Profiling Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cancer (Tumor) Profiling by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Cancer (Tumor) Profiling in Clinical

    • 4.4.2 Market Size and Growth Rate of Cancer (Tumor) Profiling in Research

    5 Market Analysis by Regions

    • 5.1 China Cancer (Tumor) Profiling Production Analysis by Regions

    • 5.2 China Cancer (Tumor) Profiling Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Cancer (Tumor) Profiling Landscape Analysis

    • 6.1 North China Cancer (Tumor) Profiling Landscape Analysis by Major Types

    • 6.2 North China Cancer (Tumor) Profiling Landscape Analysis by Major End-Users

    7 Central China Cancer (Tumor) Profiling Landscape Analysis

    • 7.1 Central China Cancer (Tumor) Profiling Landscape Analysis by Major Types

    • 7.2 Central China Cancer (Tumor) Profiling Landscape Analysis by Major End-Users

    8 South China Cancer (Tumor) Profiling Landscape Analysis

    • 8.1 South China Cancer (Tumor) Profiling Landscape Analysis by Major Types

    • 8.2 South China Cancer (Tumor) Profiling Landscape Analysis by Major End-Users

    9 East China Cancer (Tumor) Profiling Landscape Analysis

    • 9.1 East China Cancer (Tumor) Profiling Landscape Analysis by Major Types

    • 9.2 East China Cancer (Tumor) Profiling Landscape Analysis by Major End-Users

    10 Northeast China Cancer (Tumor) Profiling Landscape Analysis

    • 10.1 Northeast China Cancer (Tumor) Profiling Landscape Analysis by Major Types

    • 10.2 Northeast China Cancer (Tumor) Profiling Landscape Analysis by Major End-Users

    11 Southwest China Cancer (Tumor) Profiling Landscape Analysis

    • 11.1 Southwest China Cancer (Tumor) Profiling Landscape Analysis by Major Types

    • 11.2 Southwest China Cancer (Tumor) Profiling Landscape Analysis by Major End-Users

    12 Northwest China Cancer (Tumor) Profiling Landscape Analysis

    • 12.1 Northwest China Cancer (Tumor) Profiling Landscape Analysis by Major Types

    • 12.2 Northwest China Cancer (Tumor) Profiling Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 HTG Molecular Diagnostics

      • 13.1.1 HTG Molecular Diagnostics Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Ribomed Biotechnologies

      • 13.2.1 Ribomed Biotechnologies Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Caris Life Sciences

      • 13.3.1 Caris Life Sciences Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Helomics Corporation

      • 13.4.1 Helomics Corporation Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Neogenomics Laboratories

      • 13.5.1 Neogenomics Laboratories Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Nanostring Technologies

      • 13.6.1 Nanostring Technologies Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Genomic Health

      • 13.7.1 Genomic Health Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Qiagen

      • 13.8.1 Qiagen Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Illumina

      • 13.9.1 Illumina Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Oxford Gene Technology

      • 13.10.1 Oxford Gene Technology Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Cancer (Tumor) Profiling Market Size and Growth Rate of Immunoassay from 2016 to 2027

    • Figure China Cancer (Tumor) Profiling Market Size and Growth Rate of Hybridization from 2016 to 2027

    • Figure China Cancer (Tumor) Profiling Market Size and Growth Rate of NGS from 2016 to 2027

    • Figure China Cancer (Tumor) Profiling Market Size and Growth Rate of Mass Spectrometry from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Cancer (Tumor) Profiling Market Size and Growth Rate of Clinical from 2016 to 2027

    • Figure China Cancer (Tumor) Profiling Market Size and Growth Rate of Research from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Cancer (Tumor) Profiling Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Cancer (Tumor) Profiling Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Cancer (Tumor) Profiling

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cancer (Tumor) Profiling by Different Types from 2016 to 2027

    • Table Consumption Share of Cancer (Tumor) Profiling by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Immunoassay

    • Figure Market Size and Growth Rate of Hybridization

    • Figure Market Size and Growth Rate of NGS

    • Figure Market Size and Growth Rate of Mass Spectrometry

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Cancer (Tumor) Profiling by Different End-Users from 2016 to 2027

    • Table Consumption Share of Cancer (Tumor) Profiling by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Clinical

    • Figure Market Size and Growth Rate of Research

    • Table China Cancer (Tumor) Profiling Production by Regions

    • Table China Cancer (Tumor) Profiling Production Share by Regions

    • Figure China Cancer (Tumor) Profiling Production Share by Regions in 2016

    • Figure China Cancer (Tumor) Profiling Production Share by Regions in 2021

    • Figure China Cancer (Tumor) Profiling Production Share by Regions in 2027

    • Table China Cancer (Tumor) Profiling Consumption by Regions

    • Table China Cancer (Tumor) Profiling Consumption Share by Regions

    • Figure China Cancer (Tumor) Profiling Consumption Share by Regions in 2016

    • Figure China Cancer (Tumor) Profiling Consumption Share by Regions in 2021

    • Figure China Cancer (Tumor) Profiling Consumption Share by Regions in 2027

    • Table North China Cancer (Tumor) Profiling Consumption by Types from 2016 to 2027

    • Table North China Cancer (Tumor) Profiling Consumption Share by Types from 2016 to 2027

    • Figure North China Cancer (Tumor) Profiling Consumption Share by Types in 2016

    • Figure North China Cancer (Tumor) Profiling Consumption Share by Types in 2021

    • Figure North China Cancer (Tumor) Profiling Consumption Share by Types in 2027

    • Table North China Cancer (Tumor) Profiling Consumption by End-Users from 2016 to 2027

    • Table North China Cancer (Tumor) Profiling Consumption Share by End-Users from 2016 to 2027

    • Figure North China Cancer (Tumor) Profiling Consumption Share by End-Users in 2016

    • Figure North China Cancer (Tumor) Profiling Consumption Share by End-Users in 2021

    • Figure North China Cancer (Tumor) Profiling Consumption Share by End-Users in 2027

    • Table Central China Cancer (Tumor) Profiling Consumption by Types from 2016 to 2027

    • Table Central China Cancer (Tumor) Profiling Consumption Share by Types from 2016 to 2027

    • Figure Central China Cancer (Tumor) Profiling Consumption Share by Types in 2016

    • Figure Central China Cancer (Tumor) Profiling Consumption Share by Types in 2021

    • Figure Central China Cancer (Tumor) Profiling Consumption Share by Types in 2027

    • Table Central China Cancer (Tumor) Profiling Consumption by End-Users from 2016 to 2027

    • Table Central China Cancer (Tumor) Profiling Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Cancer (Tumor) Profiling Consumption Share by End-Users in 2016

    • Figure Central China Cancer (Tumor) Profiling Consumption Share by End-Users in 2021

    • Figure Central China Cancer (Tumor) Profiling Consumption Share by End-Users in 2027

    • Table South China Cancer (Tumor) Profiling Consumption by Types from 2016 to 2027

    • Table South China Cancer (Tumor) Profiling Consumption Share by Types from 2016 to 2027

    • Figure South China Cancer (Tumor) Profiling Consumption Share by Types in 2016

    • Figure South China Cancer (Tumor) Profiling Consumption Share by Types in 2021

    • Figure South China Cancer (Tumor) Profiling Consumption Share by Types in 2027

    • Table South China Cancer (Tumor) Profiling Consumption by End-Users from 2016 to 2027

    • Table South China Cancer (Tumor) Profiling Consumption Share by End-Users from 2016 to 2027

    • Figure South China Cancer (Tumor) Profiling Consumption Share by End-Users in 2016

    • Figure South China Cancer (Tumor) Profiling Consumption Share by End-Users in 2021

    • Figure South China Cancer (Tumor) Profiling Consumption Share by End-Users in 2027

    • Table East China Cancer (Tumor) Profiling Consumption by Types from 2016 to 2027

    • Table East China Cancer (Tumor) Profiling Consumption Share by Types from 2016 to 2027

    • Figure East China Cancer (Tumor) Profiling Consumption Share by Types in 2016

    • Figure East China Cancer (Tumor) Profiling Consumption Share by Types in 2021

    • Figure East China Cancer (Tumor) Profiling Consumption Share by Types in 2027

    • Table East China Cancer (Tumor) Profiling Consumption by End-Users from 2016 to 2027

    • Table East China Cancer (Tumor) Profiling Consumption Share by End-Users from 2016 to 2027

    • Figure East China Cancer (Tumor) Profiling Consumption Share by End-Users in 2016

    • Figure East China Cancer (Tumor) Profiling Consumption Share by End-Users in 2021

    • Figure East China Cancer (Tumor) Profiling Consumption Share by End-Users in 2027

    • Table Northeast China Cancer (Tumor) Profiling Consumption by Types from 2016 to 2027

    • Table Northeast China Cancer (Tumor) Profiling Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Cancer (Tumor) Profiling Consumption Share by Types in 2016

    • Figure Northeast China Cancer (Tumor) Profiling Consumption Share by Types in 2021

    • Figure Northeast China Cancer (Tumor) Profiling Consumption Share by Types in 2027

    • Table Northeast China Cancer (Tumor) Profiling Consumption by End-Users from 2016 to 2027

    • Table Northeast China Cancer (Tumor) Profiling Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Cancer (Tumor) Profiling Consumption Share by End-Users in 2016

    • Figure Northeast China Cancer (Tumor) Profiling Consumption Share by End-Users in 2021

    • Figure Northeast China Cancer (Tumor) Profiling Consumption Share by End-Users in 2027

    • Table Southwest China Cancer (Tumor) Profiling Consumption by Types from 2016 to 2027

    • Table Southwest China Cancer (Tumor) Profiling Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Cancer (Tumor) Profiling Consumption Share by Types in 2016

    • Figure Southwest China Cancer (Tumor) Profiling Consumption Share by Types in 2021

    • Figure Southwest China Cancer (Tumor) Profiling Consumption Share by Types in 2027

    • Table Southwest China Cancer (Tumor) Profiling Consumption by End-Users from 2016 to 2027

    • Table Southwest China Cancer (Tumor) Profiling Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Cancer (Tumor) Profiling Consumption Share by End-Users in 2016

    • Figure Southwest China Cancer (Tumor) Profiling Consumption Share by End-Users in 2021

    • Figure Southwest China Cancer (Tumor) Profiling Consumption Share by End-Users in 2027

    • Table Northwest China Cancer (Tumor) Profiling Consumption by Types from 2016 to 2027

    • Table Northwest China Cancer (Tumor) Profiling Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Cancer (Tumor) Profiling Consumption Share by Types in 2016

    • Figure Northwest China Cancer (Tumor) Profiling Consumption Share by Types in 2021

    • Figure Northwest China Cancer (Tumor) Profiling Consumption Share by Types in 2027

    • Table Northwest China Cancer (Tumor) Profiling Consumption by End-Users from 2016 to 2027

    • Table Northwest China Cancer (Tumor) Profiling Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Cancer (Tumor) Profiling Consumption Share by End-Users in 2016

    • Figure Northwest China Cancer (Tumor) Profiling Consumption Share by End-Users in 2021

    • Figure Northwest China Cancer (Tumor) Profiling Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of HTG Molecular Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HTG Molecular Diagnostics

    • Figure Sales and Growth Rate Analysis of HTG Molecular Diagnostics

    • Figure Revenue and Market Share Analysis of HTG Molecular Diagnostics

    • Table Product and Service Introduction of HTG Molecular Diagnostics

    • Table Company Profile and Development Status of Ribomed Biotechnologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ribomed Biotechnologies

    • Figure Sales and Growth Rate Analysis of Ribomed Biotechnologies

    • Figure Revenue and Market Share Analysis of Ribomed Biotechnologies

    • Table Product and Service Introduction of Ribomed Biotechnologies

    • Table Company Profile and Development Status of Caris Life Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Caris Life Sciences

    • Figure Sales and Growth Rate Analysis of Caris Life Sciences

    • Figure Revenue and Market Share Analysis of Caris Life Sciences

    • Table Product and Service Introduction of Caris Life Sciences

    • Table Company Profile and Development Status of Helomics Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Helomics Corporation

    • Figure Sales and Growth Rate Analysis of Helomics Corporation

    • Figure Revenue and Market Share Analysis of Helomics Corporation

    • Table Product and Service Introduction of Helomics Corporation

    • Table Company Profile and Development Status of Neogenomics Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neogenomics Laboratories

    • Figure Sales and Growth Rate Analysis of Neogenomics Laboratories

    • Figure Revenue and Market Share Analysis of Neogenomics Laboratories

    • Table Product and Service Introduction of Neogenomics Laboratories

    • Table Company Profile and Development Status of Nanostring Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nanostring Technologies

    • Figure Sales and Growth Rate Analysis of Nanostring Technologies

    • Figure Revenue and Market Share Analysis of Nanostring Technologies

    • Table Product and Service Introduction of Nanostring Technologies

    • Table Company Profile and Development Status of Genomic Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health

    • Figure Sales and Growth Rate Analysis of Genomic Health

    • Figure Revenue and Market Share Analysis of Genomic Health

    • Table Product and Service Introduction of Genomic Health

    • Table Company Profile and Development Status of Qiagen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen

    • Figure Sales and Growth Rate Analysis of Qiagen

    • Figure Revenue and Market Share Analysis of Qiagen

    • Table Product and Service Introduction of Qiagen

    • Table Company Profile and Development Status of Illumina

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina

    • Figure Sales and Growth Rate Analysis of Illumina

    • Figure Revenue and Market Share Analysis of Illumina

    • Table Product and Service Introduction of Illumina

    • Table Company Profile and Development Status of Oxford Gene Technology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oxford Gene Technology

    • Figure Sales and Growth Rate Analysis of Oxford Gene Technology

    • Figure Revenue and Market Share Analysis of Oxford Gene Technology

    • Table Product and Service Introduction of Oxford Gene Technology


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US